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Objectives. This study sought to determine the results of
coronary stenting in thrombus-laden lesions.
Background. The angiographic evidence of intracoronary
thrombus has classically been considered a formal contraindica-
tion to stent implantation. However, with increasing use of
stenting, the indications for this technique have widened to
include treatment of patients who have an acute coronary syn-
drome or lesions with adverse anatomic features.
Methods. We studied 86 consecutive patients (mean age 6 SD
61 6 11 years, 14 women) undergoing coronary stenting of a
thrombus-containing lesion; the procedure was performed elec-
tively in 39% and after angioplasty failure in 61%. Sixty-four
patients (75%) were treated for unstable angina, and 19 (22%)
underwent the procedure during an acute myocardial infarction. A
specific protocol that included clinical and late angiographic
follow-up was used.
Results. Angiographic success was obtained in 83 patients
(96%). Five patients (6%) died during the hospital stay despite
angiographic success; four of these had cardiogenic shock, and
one (1%) had subacute stent thrombosis. Non-Q wave myocardial
infarction developed in five additional patients (6%), and four of
these five had data consistent with distal embolization. Of the 78
patients discharged with angiographic success, 67 (86%) were
event-free and clinically improved at last follow-up visit (12 6 11
months). During the follow-up period, eight patients required
repeat angioplasty, one patient required heart transplantation,
and two patients died. Quantitative angiography demonstrated
excellent angiographic results after stenting (minimal lumen
diameter 0.31 6 0.4 vs. 2.77 6 0.6 mm). Late angiographic
follow-up (5.5 6 1 months) was obtained in 50 patients with 54
lesions (93% of eligible), revealing a minimal lumen diameter of
2.06 1 mm and restenosis (lumen narrowing >50%) in 18 lesions
(33%).
Conclusions. Coronary stenting constitutes an effective thera-
peutic strategy for patients with thrombus-containing lesions,
either after failure of initial angioplasty or electively as the
primary procedure. Coronary stenting in this adverse anatomic
setting results in a high degree of angiographic success, a low
incidence of subacute thrombosis and an acceptable restenosis
rate.
(J Am Coll Cardiol 1997;29:725–33)
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Coronary stenting is a therapeutic strategy increasingly used
during coronary interventions (1,2). The value of intracoronary
stenting as the procedure of choice for the management of
abrupt vessel closure and suboptimal angiographic results after
coronary angioplasty has been well established (1–6). Re-
cently, two major randomized trials comparing coronary stent-
ing with conventional balloon angioplasty in selected patients
with de novo lesions (7,8) demonstrated the efficacy of stent
implantation in reducing the rate of restenosis. Coronary stents
also appear to confer superior long-term clinical benefit in
these patients (9). The expanded use of coronary stenting has
been associated with the development of new strategies for
optimal stent deployment (10) and it has been bolstered by
recent data (11,12) demonstrating the excellent outcome of
patients undergoing this procedure without anticoagulation.
Nevertheless, uncertainties remain with regard to the use of
these metallic prostheses in certain clinical and anatomic
situations. Although conventional guidelines (2,13) consider
thrombus-containing lesions an absolute contraindication for
coronary stenting, this technique has been used with favorable
results in patients with an acute coronary syndrome (14–20) in
whom the underlying pathologic substrate frequently includes
intracoronary thrombi (21–23). In addition, preliminary data
(24–26) suggest the possibility of successful stent deployment
in the presence of angiographically visible thrombus. However,
procedural results and long-term clinical and angiographic
implications of coronary stenting in this setting have not been
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established. To address this issue we analyzed the clinical and
angiographic results of patients undergoing coronary stenting
in lesions with angiographic evidence of intracoronary throm-
bus.
Methods
Patient group. From March 1990 to April 1996, 659 con-
secutive patients were treated with intracoronary stenting
(742 lesions, 831 stents) at our institution. Of these, 86
patients (13%) underwent stent implantation in a thrombus-
containing lesion (88 vessels, 92 lesions), and they comprise
the study group. All patients undergoing coronary stenting
in our hospital are included in a prospective protocol
including close clinical follow-up (in a dedicated outpatient
clinic) and systematic late angiography. Procedural and
angiographic data were obtained from our coronary angio-
plasty data base and by careful review of the hospital records
and cine films.
Procedure and protocol. The protocol of coronary angio-
plasty and the technique of coronary stenting in our institution
have been described elsewhere (6,27). Balloon catheters and
the stent type were selected at the discretion of the primary
operator. Small vessels (diameter ,2.5 mm on visual estima-
tion) and those with severe proximal tortuosities or with diffuse
disease were not considered suitable for coronary stenting. A
total of 116 stents were used to treat 92 thrombus-containing
lesions in these 86 patients. Several types of stents were used in
this study (Palmaz-Schatz [Johnson and Johnson Interven-
tional Systems, n 5 71], Gianturco-Roubin Flex-stent [Cook,
n 5 21], Wallstent [Schneider, Switzerland, n 5 11], NIR stent
[Boston Scientific, n5 6], Cordis stent ([n5 3] and other types
[n 5 4)]). Stenting for thrombus-containing lesions was indi-
cated either electively, as the primary selected therapy, or
nonelectively, after unsuccessful angioplasty. Before nonelec-
tive coronary stenting, intracoronary nitroglycerin was admin-
istered to rule out vasospasm, and repeat balloon angioplasty
was always attempted after dilation failure. Alternatively,
elective coronary stenting was considered most commonly
after dilation of total occlusions or when the lesion and the
thrombotic material appeared to be easily covered by the
selected stent. Before elective coronary stenting, the lesion was
predilated. In patients in whom a large amount of thrombotic
material was suspected, a significantly undersized balloon was
used. This strategy was selected to facilitate subsequent ad-
vancement of the balloon-stent assembly without increasing
the risks of distal embolization. Special care was taken during
elective stent deployment to cover both the site of the stenosis
and the intraluminal filling defect. In patients in whom these
sites were slightly separated, the stent was located at the site
showing the most significant narrowing after predilation or,
alternatively, multiple stents were used. In this cohort of
patients, intravascular ultrasound studies were not routinely
performed during coronary stenting.
The stenting protocol was modified in two important as-
pects over the study period. Beginning in 1994, relatively high
pressure ($10 atm) balloon inflations, with noncompliant
balloons, were routinely used. This change was coincident with
the substitution of a combination of antiplatelet agents for the
classic anticoagulation regimen. Thus, the initial 25 patients
(29%) received standard anticoagulation with intravenous
heparin, dextran, aspirin and dypiridamole. In these patients
the heparin infusion was continued until a stable degree of oral
anticoagulation (international normalized ratio $3) was
achieved. The remaining 61 patients (71%) did not receive oral
anticoagulation and were treated with heparin for 24 to 48 h
and a combination of aspirin (250 mg daily) and ticlopidine
(250 mg daily) after hospital discharge. Nitrates and calcium
channel blocking agents were recommended for 6 months.
Angiographic analysis. Angiographic data were prospec-
tively evaluated by two investigators who did not know the
results of coronary stenting. Lesion characteristics were estab-
lished after the administration of 0.2 mg of intracoronary
nitroglycerin by qualitative evaluation of each lesion in differ-
ent projections (28). In this study, two previously validated
definitions (23,29,30) were used for thrombus. First, thrombus
was defined as discrete intraluminal filling defects outlined by
contrast material in at least two orthogonal projections. Sec-
ond, in the presence of a totally occluded vessel, thrombus was
considered when a readily identifiable convex edge with angio-
graphic staining or haziness could be documented at the site of
the occlusion (Fig. 1 and 2). All films were reviewed to verify
that an angiographic image strongly suggestive of thrombus
was present. Special care was taken to classify anterograde
coronary flow before and after the procedure. Vessels with
Thrombolysis in Myocardial Infarction (TIMI) grade 0 or 1
flow (31), were classified as occluded. The modified American
College of Cardiology/American Heart Association (ACC/
AHA) criteria were used to classify the target lesion (32).
Quantitative angiographic analysis was carried out off-line
without knowledge of the patient’s clinical or procedural
characteristics by an experienced operator who used a com-
mercially available, previously validated, interactive automatic
edge-detection computer program (ARTREK, Quantim
2000I, QCS, Inc, ImageComm Systems, Inc.) (33,34). End-
diastolic frames displaying the most severe lumen narrowing,
without foreshortening of the selected coronary segment, were
selected from among multiple projections. Frames with signif-
icant overlapping of the study vessel with other branches and
those in which the region of interest was not relatively centered
were rejected. The view showing the smallest minimal lumen
diameter was selected as the working projection. In our
experience this system provides good intraobserver variability
in absolute measurements (6). The distal end of the guiding
catheter was used for absolute calibration in each selected
Abbreviations and Acronyms
CK 5 creatine kinase
ECG 5 electrocardiogram, electrocardiographic
TIMI 5 Thrombolysis in Myocardial Infarction
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projection. Quantitative analysis of the follow-up angiogram
was performed, again after the administration of intracoronary
nitroglycerin, by using matching views. The reference segment
was user-defined before intervention and the same reference
segment was selected after intervention and at follow-up. A
binary definition for restenosis (stenosis .50% at follow-up
angiography) was used.
Definitions and follow-up. Angiographic success was de-
fined as successful stent deployment with a residual stenosis
,50% by quantitative angiography. Procedural success was
defined as angiographic success in the absence of major
in-hospital complications (including death, myocardial infarc-
tion or the need for coronary bypass surgery) (6,27). Complete
blood counts and serial (every 8 h) enzyme measurements and
12-lead electrocardiograms (ECGs) were obtained for 2 days
after stenting in all patients (6,27). The creatine kinase (CK)
MB isoenzyme measurement was routinely performed when an
increase in CK concentration was documented. Coronary
angiography was repeated in patients with suspected myocar-
dial ischemia to rule out subacute stent thrombosis. During
follow-up, clinical events were defined as death, myocardial
infarction or requirement for revascularization (either aorto-
coronary bypass surgery or angioplasty), whichever occurred
first. Deaths were considered to be cardiac unless a noncardiac
cause could be established. Most patients were followed up
(1 month, 6 months and yearly thereafter) in an outpatient
clinic specifically dedicated to patients undergoing interven-
tional procedures. Telephone contact with the patient or
referring physicians was also used when needed for follow-up
purposes. All patients gave informed consent to the procedure.
In addition, all patients agreed to return for routine late
clinical and angiographic follow-up 6 months after stent im-
plantation. Because some patients included in the study were
at high risk (such as those in cardiogenic shock), procedure-
related events and the events occurring after discharge were
studied separately to better evaluate the long-term implica-
tions of stent implantation in thrombus-containing lesions.
Statistical analysis. All continuous variables were ex-
pressed as mean value 6 SD. Continuous variables were
compared with a two-tailed Student t test or by using repeated
measures analysis of variance with comparison of data among
the different groups, as required. Categoric data were pre-
sented as absolute value and percent. Nonparametric tests
(chi-square and Fisher exact test) were used for discrete
variables. Rates of event-free survival were studied with
Kaplan-Meier analysis. A p value ,0.05 was considered statis-
tically significant.
Figure 1. a, Coronary angiogram revealing a complex,
severe stenosis with an intraluminal filling defect (arrow)
in the proximal right coronary artery. b and c, After
conventional balloon coronary angioplasty and despite
multiple balloon inflations, a suboptimal outcome was
obtained as the result of significant residual filling defects
(small arrows). d, Subsequent stent implantation pro-
vided an excellent angiographic result and no visible
residual thrombus (arrows).
Figure 2. A, Complete occlusion of the left anterior descending
coronary artery in a patient presenting with an acute anterior myocar-
dial infarction. Staining of contrast material and haziness (arrow) were
visualized at the site of occlusion after intracoronary nitroglycerin. B,
After several balloon inflations the artery opened, and TIMI grade 2
coronary flow was obtained, but a large filling defect (arrow) persisted
at the previously occluded site. C, Stent implantation was required to
obtain a satisfactory angiographic result (arrows) and brisk antero-
grade coronary flow.
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Results
Clinical data of the 86 study patients are listed in Table 1.
The mean age of the group was 61 6 11 years (range 37 to 80)
and 64 patients (75%) were treated for unstable angina. In 19
patients (22%) the angioplasty procedure was performed in
the acute phase of a myocardial infarction (direct angioplasty
in 16, rescue angioplasty in 3). Peak CK in these patients with
infarction was 1,813 6 1,212 U/liter. Before angioplasty 80
patients (93%) were receiving antiplatelet agents, 78 (90%)
nitrates, 75 (87%) calcium antagonist or beta-adrenergic
blocking agents (24 received triple therapy); 49 patients (57%)
were fully anticoagulated with heparin. Baseline angiographic
characteristics (88 vessels, 92 lesions) are presented in Table 2.
Most stents were implanted in the left anterior descending or
right coronary artery. Ten patients had bulky complex lesions,
with clear filling defects, located on saphenous vein grafts
(mean graft age 10.3 6 2.5 years). Of the 92 thrombus-
containing lesions, 59 (64%) had the appearance of intralumi-
nal filling defects, whereas the remaining 33 were occluded
vessels fulfilling the previously defined criteria for thrombus.
Of these occluded vessels, 17 were in patients with acute
myocardial infarction; in the remaining 16 occluded vessels,
the clinically estimated occlusion time was 30 6 14 days (4
patients had chronic [.3 months] occlusions).
The most relevant procedural data are presented in Table 3.
In 30 patients (35%) the angioplasty procedure was considered
an emergency, and in 39 (45%) it was performed during
diagnostic coronary angiography. Intraaortic balloon pumping
was required in 6 patients. In 62 lesions (67%) high pressure
(.10 atm) inflations were used. In most patients a single stent
was used at the target lesion. However, multiple stenting was
required in 17 lesions (four stents in 3 lesions, three stents in
1 lesion, two stents in 13 lesions). Elective stenting was used in
36 lesions (39%). However, most patients in this series under-
went coronary stenting after unsuccessful angioplasty. Athe-
rectomy was initially performed in four of these patients
(directional atherectomy in two extraction atherectomy in
two), but in the remaining patients conventional balloon
angioplasty was used. Before nonelective stenting was per-
formed, repeat dilations (mean number 7 6 4) and prolonged
balloon inflations (total inflation time 440 6 290 s) were
unsuccessful in providing a satisfactory angiographic result.
Intracoronary urokinase was administered in three patients
before stent implantation.
Procedural and in-hospital results. Of the 86 study pa-
tients, 83 (96%) had successful stent implantation. In three
patients with occluded vessels after initial balloon angioplasty,
the stent was deployed at the target site but was unsuccessful in
opening up the vessel (despite the use of two stents in one
patient and intracoronary urokinase in two patients). In all
three patients large residual filling defects could be appreci-
ated at some point within the stent or its boundaries during the
procedure. These three patients with dilation failure had a
nonfatal Q wave myocardial infarction. Despite initial angio-
graphic success five additional patients (6%) had a non-Q wave
Table 1. Baseline Clinical Characteristics of 86 Study Patients
Age (yr) 61 6 11
Female 14 (16%)
Clinical presentation
Unstable angina 64 (75%)
Stable angina 3 (3%)
Acute MI 19 (22%)
Anterior 10
Inferior 9
Cardiogenic shock 6 (7%)
Previous intravenous thrombolysis 17 (19%)
Prior MI 51 (59%)
Prior CABG surgery 10 (11%)
Data are presented as mean value 6 SD or number (%) of patients.
CABG 5 coronary artery bypass graft; MI 5 myocardial infarction.
Table 2. Baseline Angiographic Findings (88 vessels, 92 lesions)
LVEF (%)* 61 6 16
Multivessel disease 48 (56%)
Collateral circulation 16 (19%)
Target vessel
LMCA 4 (4%)
LAD 34 (39%)
RCA 35 (40%)
LCx 5 (6%)
SVG 10 (11%)
TIMI flow grade 0–1 33 (36%)
Calcified lesion 14 (15%)
ACC/AHA classification
B1 3 (3%)
B2 57 (62%)
C 32 (35%)
*Measurement not performed in 19 patients in unstable clinical condition.
Data are expressed as mean value 6 SD or number (%) of patients. ACC/
AHA 5 American College of Cardiology/American Heart Association classifi-
cation; LAD 5 left anterior descending coronary artery; LCx 5 left circumflex
coronary artery; LMCA 5 left main coronary artery; LVEF 5 left ventricular
ejection fraction; RCA 5 right coronary artery; SVG 5 saphenous vein graft;
TIMI 5 Thrombolysis in Myocardial Infarction trial coronary flow.
Table 3. Procedural Data for 86 Study Patients
Indications for stenting
Elective (planned) 36 (39%)
Angioplasty failure 56 (61%)
Suboptimal result 29 (32%)
Threatened closure (thrombus/dissection) 27 (29%)
Largest balloon diameter (mm) 3.56 0.4
Maximal pressure (atm) 11.86 4
Dilation of other lesions 8 (14%)
Multiple stenting at the target lesion 17 (18%)
Average no. of stents/patient 1.3
TIMI flow after stenting
0–1 3 (3%)
2 4 (4%)
3 85 (93%)
Data presented are mean value 6 SD or number (%) of patients. TIMI 5
Thrombolysis in Myocardial Infarction trial coronary flow grade.
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myocardial infarction after the procedure with mild enzyme
changes (mean CK peak 5 466 6 52 U/liter). In four of them
a slow flow (TIMI grade 2), highly suggestive of distal embo-
lization was documented during stenting (in one patient before
and in three patients during stent deployment). In the remain-
ing patient the non-Q wave myocardial infarction was the
result of a dilation at a different site. Angiographic data
consistent with distal embolization into a small branch were
documented in two additional patients who remained asymp-
tomatic and showed no enzyme or ECG changes. Five patients
(6%) died during the hospital stay despite initial angiographic
success. Three patients, who had cardiogenic shock during a
myocardial infarction, eventually died from multiorgan failure
(two patients within 24 h, one patient 2 weeks later). Another
patient, awaiting cardiac surgery for severe left main coronary
artery stenosis, suddenly collapsed in the intensive care unit
with electromechanical dissociation. After 30 min of unsuc-
cessful cardiopulmonary resuscitation maneuvers he was
brought to the catheterization laboratory where the left main
stem was found occluded. An excellent angiographic result was
obtained after stent implantation. Although the patient briefly
regained hemodynamic stability and an intraaortic balloon
pump was implanted, he died 4 h later in cardiogenic shock.
None of these four patients presented ECG changes suggestive
of subacute stent thrombosis. The last patient who died had
successful placement of two stents in the left anterior descend-
ing coronary artery during a primary angioplasty of a large
anterior myocardial infarction. Subsequently, he remained
asymptomatic, but 8 days later he died from refractory ventric-
ular arrhythmias. Autopsy examination (Fig. 3) disclosed a
massive anterior myocardial infarction and thrombosis of the
stents. No other patient in this series had clinical data sugges-
tive of stent thrombosis. There were no referrals for coronary
artery bypass grafting. Four patients (three receiving oral
anticoagulation) required vascular surgery for hemorrhagic
complications. No other events were documented during the
hospital stay. Thus, angiographic success without complica-
tions was eventually obtained in 73 patients (85%). Procedural
success was not related to the implantation strategy (Table 4).
Clinical follow-up. Clinical follow-up was obtained in the
78 patients who were discharged with angiographic success. At
last clinical follow-up (mean 126 11 months, range 1 to 67), 67
(86%) of these patients were event-free and clinically im-
proved. Eight patients underwent repeat coronary angioplasty
(four for restenosis, four for treatment at a different site)
because of recurrence of symptoms (unstable angina in six
non-Q wave myocardial infarction in two). One patient with
extensive coronary artery disease and very poor left ventricular
Figure 3. Pathologic findings in
the patient who experienced sub-
acute stent thrombosis and died. A
large thrombus completely occlud-
ing the coronary lumen is visual-
ized. Histologic analysis revealed
different stages of thrombus orga-
nization at various levels. The cir-
cular and semilunar empty spaces
(stars) represent the fingerprints
of the removed Gianturco-Roubin
stent.
Table 4. Procedural Success in the 92 Stented Lesions in Relation to Implantation Strategy
Elective High Pressure Oral Anticoagulation
Yes No Yes No Yes No
Success 30 (83%) 49 (87%) 54 (87%) 25 (83%) 24 (89%) 55 (84%)
Failure 6 (17%) 7 (13%) 8 (13%) 5 (17%) 3 (11%) 10 (16%)
Data presented are number (%) of lesions.
729JACC Vol. 29, No. 4 ALFONSO ET AL.
March 15, 1997:725–33 STENTING IN LESIONS WITH THROMBUS
function had successful orthotopic heart transplantation. Two
patients died after a myocardial infarction during follow-up.
Figure 4 shows the event-free survival, on actuarial analysis, of
the 86 initial patients (including those who died from cardio-
genic shock).
Angiographic follow-up. Late angiography was not avail-
able in one of the patients who died before 6 months and in the
heart transplant recipient. Four patients refused repeat an-
giography; all of them were asymptomatic and had a negative
exercise test result. Accordingly, late angiography (5.5 6 1
months after stenting) was performed in 50 patients (54
lesions) (93%) of the 54 eligible patients (elapsed time from
stenting .6 months). Figure 5 displays early and late results of
quantitative angiography. Minimal lumen diameter was 0.3 6
0.4 mm before dilation, 2.776 0.6 mm after stenting and 2.06
1 mm at follow-up. Restenosis, using the .50% lumen nar-
rowing binary definition, was found in 18 lesions (33%).
Twelve patients with restenosis were asymptomatic, whereas
four had symptoms and required a new angioplasty. There was
a trend to a lower restenosis rate for stents implanted electively
(5 [23%] vs. 13 [39%], p 5 0.1), but the use of high pressures
or oral anticoagulation did not influence the restenosis rate.
Discussion
Theoretically, the implantation of inherently thrombogenic
metallic prostheses in patients with thrombotic material at the
lesion site may present a nidus for further clot propagation.
Accordingly, the deployment of stents in thrombus-laden
lesions has been avoided until recently (2,13). Nevertheless,
striking advances in antithrombotic regimens and implantation
techniques have resulted in a dramatic increase in the appli-
cation of these devices with a concomitant reduction in asso-
ciated complications (11,12). In fact, the use of intracoronary
stents, either electively or after dilation failure, in patients with
an acute ischemic syndrome has gained widespread clinical
acceptance (14–18). In these patients pathologic, angiographic
and angioscopic data (21–23) have demonstrated that intra-
coronary thrombus is frequently present in the underlying
substrate. To our knowledge, however, the present investiga-
tion is the first systematic study assessing the results of
coronary stenting in a large series of consecutive patients with
thrombus-containing lesions. Our patients were a rather het-
erogeneous cohort, but all showed angiographic evidence of
thrombus at the lesion site. A significant subset were at high
risk (including patients with cardiogenic shock, left main
coronary artery disease or rescue angioplasty), and 61% of
them required coronary stenting after failure or complication
of a previous angioplasty. Nevertheless, the clinical results
obtained in most of these patients were highly satisfactory
considering that four of the five hospital deaths occurred in
patients presenting with cardiogenic shock (35).
The most noteworthy finding of our study was the excellent
angiographic result obtained with stent implantation in
thrombus-containing lesions. Moreover, the incidence of sub-
acute stent thrombosis (1%) was much lower than expected. In
addition, our protocol with systematic use of late angiography
demonstrated that the restenosis rate of these patients was
acceptable and within the range of previous studies that also
used quantitative angiography (7,8). However, this restenosis
rate is probably higher than the rate that can now be obtained
in selected patients with optimal anatomy by using current
techniques of stent deployment (36,37). All these findings
suggest that coronary stenting constitutes an attractive coro-
nary intervention in patients with thrombus-containing lesions
provided that a good initial angiographic result is obtained. In
some patients the angiographic image suggestive of thrombus
is slightly displaced from the proximal part of the target lesion.
In these patients efforts should be made to completely cover
both structures with the stent. If ultimately this cannot be
achieved and significant residual stenosis or filling defects
persist, additional stent implantation should be considered.
Figure 5. Bar graph showing coronary artery diameter of reference
segment (Ref Diam [open bar]) and stented site (solid bars) as
assessed by quantitative angiographic analysis. *p , 0.05, minimal
lumen diameter after stenting (MLD-Post) versus after follow-up
(MLD-FU). **p , 0.01, minimal lumen diameter before (MLD-Pre)
versus after stenting and after follow-up.
Figure 4. Kaplan-Meier life-table analysis depicting event-free sur-
vival for the 86 patients undergoing stent implantation in thrombus-
containing lesions. Numbers in parentheses represent the number of
patients at risk at each time interval. MI 5 myocardial infarction;
PTCA 5 percutaneous transluminal coronary angioplasty.
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Recently Kaul et al. (25) reported on Palmaz-Schatz stent
implantation in 12 patients with lesions with angiographically
visible thrombus. In that study, all procedures were successful
without major complications or the development of subacute
stent thrombosis. Our findings also confirm preliminary data
from Grinstead et al. (24) and Romero et al. (26) suggesting
that elective stent implantation or stent deployment after
failure of conventional angioplasty provides good clinical and
angiographic results in thrombus-laden lesions. In contrast,
some previous studies (1,2,7,8,13) suggested that one of the
most important angiographic characteristics associated with
subacute stent thrombosis is the presence of a coronary
thrombus before or after stent deployment. However, most of
the latter studies were performed before the widespread use of
recently developed techniques for optimal stent deployment
and newer antithrombotic therapies, at a time when subacute
stent thrombosis remained a relatively frequent complication
(1–5,7,8). In addition, multiple adverse factors that usually
coincide in patients with thrombus-containing lesions may
explain the less favorable results. In fact, in a recent multi-
center study focused on identifying predictors of major adverse
events after coronary stenting (38), the presence of an angio-
graphically obvious thrombus was not associated, by multivar-
iate analysis, with an adverse outcome; only in those patients
undergoing elective stenting did this factor appear to confer a
worse prognosis. However, our findings suggest that elective
coronary stenting may constitute a reasonable alternative for
selected patients with thrombus-containing lesions. Another
previous concern was that the immediate angiographic benefits
of coronary stenting in lesions with thrombus might be over-
shadowed by a higher rate of subacute stent thrombosis or late
restenosis. Neither of these were documented in the present
study. Finally, our results demonstrate an excellent clinical
prognosis for patients with successful stent implantation in this
particular setting.
The exact mechanisms leading to an excellent angiographic
result after coronary stenting in a thrombus-containing lesion
remain undetermined and are beyond the scope of the present
study. However, our data suggest that the potentially throm-
bogenic stimulus of stents implanted in lesions with thrombus
is counterbalanced by the brisk anterograde coronary flow
associated with a widely patent lumen and absence of residual
stenosis. The specific changes in lesion geometry after stent
implantation may also provide some advantages over balloon
angioplasty in this particularly thrombogenic environment. In
vitro studies (39) have demonstrated that a large lumen and
unrestricted coronary flow are the major factors preventing
clot progression. The scaffolding properties of stents physically
contain the thrombotic material, preventing its protrusion into
the flowing blood, which could induce turbulence and increase
thrombogenicity. Therefore, it is tempting to speculate that the
residual thrombus anchored within the stent struts progres-
sively disappears as the result of endogenous fibrinolysis or,
alternatively, becomes organized and incorporated into the
vessel wall. Minor distal thrombus embolization cannot be
completely excluded (either during initial dilation or during
stent deployment), but significant “late” embolization appears
to be rare. Finally, the role of adjunctive thrombolysis at the
time of coronary stenting in thrombus-containing lesions re-
mains unsettled. However, the negative results of the Throm-
bolysis and Angioplasty in Unstable Angina (TAUSA) trial
(40), where the addition of thrombolytic agents before conven-
tional dilation of complex lesions increased the rate of adverse
events, together with the good angiographic results obtained
with conventional treatment in our series, do not appear to
justify the potential risk associated with this therapy.
Previous studies of stenting in a thrombotic milieu. Sev-
eral studies (14–17) have demonstrated that the indications for
coronary stenting can be expanded and that the technique can
provide excellent angiographic results even in nonideal situa-
tions. Recently, it was demonstrated (14) that immediate
results and complications of stenting were similar in patients
with stable and unstable coronary syndromes. In addition,
direct coronary angioplasty has been increasingly used for
mechanical revascularization in patients presenting with acute
myocardial infarction (41,42), and several studies (15–17,
41,42) have demonstrated that selected patients with acute
myocardial infarction and a failed balloon angioplasty may
benefit from scaffolding of the coronary wall. Garcı´a-Cantu et
al. (17) reported clinical success in 33 of 35 patients undergo-
ing coronary stenting as an adjunct to primary or rescue
angioplasty, within the 1st 24 h of acute myocardial infarction.
Although one third of the patients had angiographic evidence
of thrombus after the initial angioplasty, no patient showed
stent occlusion at repeat coronary angiography routinely per-
formed before hospital discharge (17). In contrast, the role of
intracoronary stenting in totally occluded vessels (another well
demonstrated thrombotic milieu) (22,23) remains to be eluci-
dated (18–20). The same factors responsible for the high
incidence of acute vessel closure or restenosis after coronary
angioplasty in occluded coronary arteries may play a role after
stenting (23). However, several investigators (18,19) have
suggested that, in selected patients with occluded vessels, stent
placement is not associated with a higher risk of subacute stent
thrombosis and may be beneficial. Furthermore, preliminary
data from prospective randomized trials (20) comparing con-
ventional angioplasty with elective coronary stenting suggest
that stent implantation in occluded vessels is associated with a
significant long-term angiographic benefit.
Study limitations. Several potential limitations of this
study must be considered. First, our study included a consec-
utive series of patients presenting with various clinical indica-
tions. This rather heterogeneous patient group constitutes a
study limitation but also provides a more comprehensive
picture of the real world of patients with an acute coronary
syndrome and thrombus-laden lesions undergoing coronary
intervention. Second, the inclusion of high risk patients, such
as those in cardiogenic shock, explains a relatively high hospital
mortality rate as the result of progressive hemodynamic dete-
rioration. Accordingly, this should not be used to argue against
the benefits of coronary stenting in lesions with thrombus. In
addition, our definition of procedural success was rather strict
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and patients with angiographic success but presenting an
asymptomatic and small rise in CK levels were considered to
have had a procedural failure. Third, the stenting protocol was
changed during the study period. However, the use of high
inflation pressures and the abandonment of oral anticoagula-
tion reflect current trends in clinical practice and were not
related to procedural results or the restenosis rate in our series.
Conclusions and clinical implications. Our findings sug-
gest that coronary stenting constitutes a safe and effective
strategy for selected patients with thrombus-containing lesions
and can provide satisfactory initial and long-term angiographic
results in this particularly adverse anatomic setting. At present
it is reasonable to use coronary stents for thrombus-containing
lesions that are resistant or became complicated after treat-
ment with conventional balloon angioplasty. Most patients
with these lesions will obtain long-term clinical and angio-
graphic benefit. Moreover, our data raise the possibility that
elective coronary stenting might be used as the treatment of
choice in selected patients with lesions bearing angiographic
evidence of intracoronary thrombus. Recent data (43) have
demonstrated that thrombus-containing lesions not only have a
lower initial success rate after balloon dilation but also have a
much higher restenosis rate. Because coronary stenting can
achieve a better initial angiographic result, has a low incidence
of subacute closure and an acceptable restenosis rate, this
strategy may prove superior to conventional balloon angio-
plasty in these patients. Finally, no patient in the present study
was treated with platelet glycoprotein IIb/IIIa receptor block-
ing drugs, which appear to be highly effective during coronary
interventions in high risk patients with unstable angina (44,45).
The potential additional benefit of this therapy during coro-
nary stenting for thrombus-laden lesions warrants prospective
evaluation.
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